Srinivasan Chandrasekhar

Title: Innovations by Srinivasan Chandrasekhar

Introduction

Srinivasan Chandrasekhar is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of oncology through his innovative approaches to treating resistant tumors. With a total of 3 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

Chandrasekhar's latest patents include methods for treating resistant tumors. The present invention provides methods for reversing multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene. This invention also provides methods for treating neoplasms in a mammal, which comprises administering to a mammal in need of this treatment a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene in combination with an oncolytic agent.

Career Highlights

Chandrasekhar is currently associated with Eli Lilly and Company, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on overcoming challenges in cancer treatment, particularly in addressing drug resistance.

Collaborations

Some of his notable coworkers include Anne H Dantzig and Robert L Shepard, who contribute to the collaborative efforts in research and development at Eli Lilly and Company.

Conclusion

Srinivasan Chandrasekhar's contributions to oncology through his patents and collaborative work highlight his commitment to advancing cancer treatment. His innovative methods for treating resistant tumors represent a significant step forward in the fight against cancer.